Article
Use and assessment of PSA in prostate cancer.
The Medical clinics of North America - 1 Jan 2011
Gjertson Carl K, Albertsen Peter C
Abstract excerpt
Since the introduction of prostate-specific antigen (PSA) screening in the late 1980s, more prostate cancers have been detected, and at an earlier stage. As a consequence, the majority of prostate cancers are now detected years before the emergence of clinically evident disease, which usually represents locally advanced or metastatic cancer. PSA screening has remained controversial, because many of the prostate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
